PATENT V/S MONOPOLY-A CASE STUDY

  • Mahendra Meena
  • Jitendra Kumar Badjatya

Abstract

Provisions of Compulsory License balance this law between interest of Inventor & public as through these provisions License can be provided to others if the invention did not use sufficiently for Public.


In case of medicine this law remains in debate from its beginning as Drugs are essential & Life saving commodities & monopoly on drugs products can make them inaccessible to poor people.


Big Pharma players tries to extend monopoly on their patented products through subsequently filling frivolous Patents as report says that most of the Patents filed remain as minor modifications than any breakthrough invention. This practice doesn’t provide more new Drugs molecules which can help in fighting new form of disease, through this practice Pharma companies only tries to increase their profits.

Keywords: Patent, IPAB, Glivec.

Downloads

Download data is not yet available.

References

1. Lakshman, N (July 2012) India refuses to hike cancer drug price, The Hindu, Retrieved from http://www.thehindu.com/news/national/india-refuses-to-hike-cancer-drug-price/article3632391.ece
2. Selvaraj, S (April, 2013) Patent Justice, The Hindu, Retrieved from http://www.thehindu .com /news /national/patent-justice/ article 4588895.ece.
3. Basheer, S (April, 2013) Novartis verdict will help genuine drug innovation, The Hindu, Retrieved from http://www.thehindu.com /news/cities/bangalore/novartis-verdict-will-help-genuine-drug-innovation/article4585550.ece.
Statistics
62 Views | 67 Downloads
How to Cite
Meena, M., and J. Badjatya. “PATENT V/S MONOPOLY-A CASE STUDY”. International Journal of Drug Regulatory Affairs, Vol. 1, no. 2, Feb. 2018, pp. 59-60, doi:https://doi.org/10.22270/ijdra.v1i2.111.